Craft
CSL

CSL

Revenue

$10.5 B

FY, 2022

Market Capitalization

$15.1 B

2022-09-20

CSL Summary

Company summary

Overview
CSL is a biotech company providing life-saving medicines. It develops and delivers biotherapies and influenza vaccines, plasma-derived therapeutics, and other solutions.
Type
Public
Founded
1916
HQ
Parkville, AU | view all locations
Website
https://www.csl.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Paul Perreault

    Paul Perreault, Chief Executive Officer and Managing Director

  • Greg Boss

    Greg Boss, Executive Vice President Legal and CSL Limited Group General Counsel

  • Bill Campbell

    Bill Campbell, Executive Vice President and Chief Commercial Officer

  • Elizabeth Walker

    Elizabeth Walker, Executive Vice President, Chief Human Resources Officer

LocationsView all

2 locations detected

  • Parkville, VIC HQ

    Australia

    45 Poplar Rd

  • King of Prussia, PA

    United States

    1020 1st Ave

CSL Financials

Summary financials

Revenue (FY, 2022)
$10.5B
Gross profit (FY, 2022)
$6.4B
Net income (FY, 2022)
$2.3B
Cash (FY, 2022)
$10.4B
EBIT (FY, 2022)
$2.9B
Enterprise value
$14.4B

Footer menu